We are live on
!
Find out more
BAM
Broadcrest Asset Management Portfolio holdings
AUM
$44.1M
1-Year Est. Return
4.51%
This Fund
S&P 500
This Quarter
Est. Return
+5.86%
1 Year Est. Return
-4.51%
3 Year Est. Return
+54.14%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$91.6M
AUM Growth
+$4.02M
(+4.6%)
Cap. Flow
+$1.24M
Cap. Flow
% of AUM
1.35%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
4
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Techne
TECH
|
+$7.94M |
| 2 |
Transcat
TRNS
|
+$3.05M |
| 3 |
Enovis
ENOV
|
+$2.58M |
| 4 |
Tyler Technologies
TYL
|
+$1.63M |
| 5 |
Nomad Foods
NOMD
|
+$1.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertiv
VRT
|
+$15.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 56.93% |
| 2 | Healthcare | 26.58% |
| 3 | Consumer Staples | 9.41% |
| 4 | Technology | 7.08% |
Similar funds
MAM
WCPI
NLVP
WAMC
CIEP
IPI
CC
VSAM
Broadcrest Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, Broadcrest Asset Management held 8 positions worth $91.6M, up 4.6% from $87.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Broadcrest Asset Management's Q4 2022 filing shows 1 new, 4 increased and 1 closed positions. Its largest new stake was Bio-Techne: 100,000 shares worth $8.29M. The largest sale was Vertiv, an estimated $15.6M.
By sector, the portfolio is most concentrated in Industrials at 57% of assets, down from 74% a quarter earlier, followed by Healthcare and Consumer Staples.
- Broadcrest Asset Management's largest Q4 2022 buy was Bio-Techne: 100,000 shares worth $8.29M.
- Broadcrest Asset Management added most to Transcat in Q4 2022, an estimated $3.05M increase.
- Broadcrest Asset Management fully exited Vertiv in Q4 2022, selling an estimated $15.6M.
- Broadcrest Asset Management's ten largest holdings make up 100% of its $91.6M portfolio in Q4 2022.
- Broadcrest Asset Management opened 1 new position and closed 1 in Q4 2022.
- Broadcrest Asset Management's portfolio value rose 4.6% quarter-over-quarter to $91.6M.
Based on Broadcrest Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.